Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215, USA.
AJR Am J Roentgenol. 2010 Jan;194(1):145-50. doi: 10.2214/AJR.08.1999.
The objective of our study was to test a dose reduction protocol that uses combined vascular-excretory phase scanning achieved by split IV contrast injection and compare it with conventional multiphase MDCT angiography (MDCTA) in evaluating potential renal donors.
This study is a review of MDCTA examinations of 54 potential renal donors scanned on 16- and 64-MDCT. The IV bolus was split: 50 mL was administered 3 minutes before scanning and a second injection of 70-100 mL was administered at a rate of 4-6 mL/s, with CT angiography started by bolus tracking. The second vascular (venous) phase was acquired 20 seconds later. Two readers reviewed the two phases, assessed vascular and parenchymal anatomy and variants or abnormalities, graded the added value of the venous phase on a 5-point scale, and took attenuation measurements in Hounsfield units. The operative notes of 39 subjects were reviewed as the reference standard for anatomic findings and compared with CT reports.
All of the relevant anatomy findings, according to the operative notes, were accurately depicted by MDCTA, and all were well recognized on the arterial phase. The arterial phase combined information from the arterial, venous, parenchymal, and excretory phases. The venous phase was inferior to the arterial phase in assessing the renal arteries without additional venous, parenchymal, or excretory phase information. The mean renal artery attenuation was 355 HU in the first phase versus 173 HU in the second phase (p<0.0001). The mean renal vein attenuation was not significantly different between the two phases. The parenchymal system and excretory system were equally well depicted in both vascular phases.
Split-bolus contrast injection and combined vascular-excretory phase scanning are adequate for studying potential renal donors and result in a marked decrease in multiphase scanning and, thus, in radiation dose.
我们的研究目的是测试一种使用通过静脉对比剂分段注射实现的血管-排泄期扫描的剂量减少方案,并将其与传统的多层螺旋 CT 血管造影(MDCTA)进行比较,以评估潜在的肾供体。
本研究回顾性分析了 54 例潜在肾供者的 MDCTA 检查,这些供者均在 16 层和 64 层 MDCT 上进行扫描。静脉团注分两次进行:扫描前 3 分钟给予 50ml,然后以 4-6ml/s 的速度给予 70-100ml 的第二次注射,以团注追踪开始 CT 血管造影。20 秒后采集第二期血管(静脉)期。两名读者分别对这两个阶段进行评估,评估血管和实质解剖及变异或异常,根据 5 分制对静脉期的附加价值进行分级,并以亨氏单位进行衰减测量。回顾 39 例患者的手术记录作为解剖学发现的参考标准,并与 CT 报告进行比较。
根据手术记录,所有相关的解剖学发现均由 MDCTA 准确显示,所有发现均在动脉期得到很好的识别。动脉期结合了动脉期、静脉期、实质期和排泄期的信息。在没有附加静脉、实质或排泄期信息的情况下,静脉期在评估肾动脉方面不如动脉期。第一期肾动脉平均衰减值为 355Hu,第二期为 173Hu(p<0.0001)。两期肾静脉平均衰减值无显著差异。实质系统和排泄系统在两个血管期均得到很好的显示。
分段对比剂注射和联合血管-排泄期扫描足以用于研究潜在的肾供体,并导致多期扫描显著减少,从而降低辐射剂量。